Related Experiment Videos
Effects of biological response modifiers on ovarian carcinoma cell lines
1Department of Obstetrics and Gynecology, University Hospital, Innsbruck, Austria.
Abstract:
Interferons have a mechanism of action different from chemotherapeutic agents. They modulate many physiologically important cellular functions and are a major building block in the network constructed by the biological response modifiers. Moreover, interferons are known to interact also with anticancer drugs to increase their therapeutic benefit. The aim of the present study was to evaluate the effects of interferon-gamma on cultured ovarian carcinoma cell lines. The growth of 3 out of 4 carcinoma cell lines (OVCAR-3, HTB-77, 2780 vs CRL-1572) was inhibited by interferon-gamma. The same cell lines which were growth inhibited also showed an induction of HLA-DR on their surface. CA-125 was found to be increased in 2 of them (OVCAR-3 and HTB-77) by interferon-gamma, whereas CEA was not detectable even after treatment. For HMFG-I, a shightly increased surface expression was induced on OVCAR-3 cells. HMFG-II expression was not significantly affected by interferon-gamma. The combined treatment with interferon-gamma and cisplatin, retinoic acid, or tumor necrosis factor alpha was studied on the ovarian carcinoma cells. For the combination with cisplatin we observed an additive or synergistic amplification of the antiproliferative activity, whereas tumor necrosis factor alpha resulted in a marked synergism in each case. In contrast to breast cancer cells retinoic acid and interferon-gamma acted synergistically only in one ovarian carcinoma cell line.
Insights
Interferon-gamma inhibited ovarian carcinoma cell growth and increased HLA-DR expression. Combinations with cisplatin and tumor necrosis factor alpha showed synergistic effects, enhancing therapeutic potential.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Interferons (IFNs) are biological response modifiers with distinct mechanisms from chemotherapy.
- IFNs modulate cellular functions and can enhance the therapeutic efficacy of anticancer drugs.
- Ovarian carcinoma remains a significant health challenge, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the effects of interferon-gamma (IFN-γ) on cultured human ovarian carcinoma cell lines.
- To evaluate the impact of IFN-γ on cell growth, surface marker expression, and in combination with other anticancer agents.
Main Methods:
- Treatment of four ovarian carcinoma cell lines (OVCAR-3, HTB-77, 2780, CRL-1572) with IFN-γ.
- Analysis of cell growth inhibition, HLA-DR, CA-125, CEA, HMFG-I, and HMFG-II expression.
- Assessment of combined effects of IFN-γ with cisplatin, retinoic acid, and tumor necrosis factor alpha (TNF-α).
Main Results:
- IFN-γ inhibited the growth of three out of four ovarian carcinoma cell lines.
- Upregulation of HLA-DR surface expression was observed in growth-inhibited cell lines.
- CA-125 increased in two cell lines; CEA remained undetectable.
- Combined treatment with IFN-γ and cisplatin showed additive or synergistic effects.
- Combinations of IFN-γ with TNF-α demonstrated marked synergism.
- Synergistic effects with retinoic acid were observed in only one cell line.
Conclusions:
- Interferon-gamma exhibits direct antiproliferative effects on a subset of ovarian carcinoma cell lines.
- IFN-γ modulates key surface markers and enhances the efficacy of certain anticancer drugs, particularly TNF-α and cisplatin.
- These findings suggest potential therapeutic applications for IFN-γ, alone or in combination, for ovarian cancer treatment.